MAX Chat
Company Analysis Fortis Malar Hospitals Limited
1. Summary
Advantages
- The stock's return over the last year (7.85%) is higher than the sector average (-28.21%).
Disadvantages
- Price (65.8 βΉ) is higher than fair price (2.96 βΉ)
- Dividends (0%) are below the sector average (0.5686%).
- The company's current efficiency (ROE=1.3%) is lower than the sector average (ROE=9.11%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Fortis Malar Hospitals Limited | Materials | Index | |
|---|---|---|---|
| 7 days | -0.2% | -20.3% | 0.5% |
| 90 days | -9.4% | -20.6% | 0.3% |
| 1 year | 7.9% | -28.2% | -3.3% |
523696 vs Sector: Fortis Malar Hospitals Limited has outperformed the "Materials" sector by 36.07% over the past year.
523696 vs Market: Fortis Malar Hospitals Limited has outperformed the market by 11.11% over the past year.
Stable price: 523696 is not significantly more volatile than the rest of the market on "Bombay Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 523696 with weekly volatility of 0.151% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (65.8 βΉ) is higher than the fair price (2.96 βΉ).
Price is higher than fair: The current price (65.8 βΉ) is 95.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (313.9) is higher than that of the sector as a whole (251.96).
P/E vs Market: The company's P/E (313.9) is higher than that of the market as a whole (124.6).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.07) is lower than that of the sector as a whole (177.73).
P/BV vs Market: The company's P/BV (4.07) is lower than that of the market as a whole (53.23).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.52) is lower than that of the sector as a whole (185.08).
P/S vs Market: The company's P/S indicator (1.52) is lower than that of the market as a whole (76.02).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0) is lower than that of the sector as a whole (0.6819).
EV/Ebitda vs Market: The company's EV/Ebitda (0) is lower than that of the market as a whole (9.65).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -20.88% over the last 5 years.
Earnings Slowdown: The last year's return (-99.14%) is below the 5-year average return (-20.88%).
Profitability vs Sector: The return for the last year (-99.14%) is lower than the return for the sector (14.23%).
5.4. ROE
ROE vs Sector: The company's ROE (1.3%) is lower than that of the sector as a whole (9.11%).
ROE vs Market: The company's ROE (1.3%) is lower than that of the market as a whole (12.03%).
5.5. ROA
ROA vs Sector: The company's ROA (1.06%) is lower than that of the sector as a whole (6.18%).
ROA vs Market: The company's ROA (1.06%) is lower than that of the market as a whole (6.81%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.64%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (13.68%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5686%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.8.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (20319.49%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
